Streamlining Endocrinology Prior Authorizations with Cohere Health

Klivira streamlines **endocrinology Cohere Health** prior authorizations, accelerating approvals for high-volume medications and devices critical to diabetes and metabolic care.

Endocrinology practices face significant administrative burdens from prior authorizations, particularly for high-cost medications and devices like GLP-1s, CGMs, and insulin pumps. Navigating diverse payer requirements, including those managed by platforms like Cohere Health, demands efficient, integrated solutions. Klivira automates the PA process, ensuring timely submissions and reducing staff workload.

The Prior Authorization Landscape in Endocrinology

Endocrinology involves managing complex conditions like diabetes, thyroid disorders, and growth hormone deficiencies, often requiring prior authorization for critical medications and devices. High-volume categories include GLP-1 agonists, continuous glucose monitors (CGMs), and insulin pumps, where payer policies frequently reference standards from the ADA, AACE, and ATA. The administrative burden for these PAs can significantly impact patient access and clinic efficiency.

Key Prior Authorization Triggers in Endocrinology

GLP-1 Receptor Agonists (e.g., semaglutide, tirzepatide) for T2D and obesity
Dual GIP/GLP-1 Agonists (e.g., tirzepatide)
Continuous Glucose Monitoring (CGM) systems (e.g., Dexcom, FreeStyle Libre)
Insulin Pumps and associated supplies
Growth Hormone Therapy (e.g., somatropin biosimilars)
SGLT2 Inhibitors for T2D, heart failure, or CKD

Navigating Cohere Health for Endocrinology Approvals

Cohere Health operates as an AI-driven prior authorization platform utilized by various payers, including Humana and GeisingerHealth Plan, to manage medical and pharmacy benefit authorizations. For endocrinology practices, this means interacting with Cohere's digital workflows for a range of services, from medication approvals to durable medical equipment. Efficiently engaging with such payer-side platforms is crucial for timely care delivery.

Klivira's Automated Solution for Endocrinology and Cohere Health

Klivira integrates directly with EMR systems via SMART on FHIR and connects with payer portals, including those powered by Cohere Health, to automate prior authorization submissions. Our platform leverages ADA/AACE-guideline-aware logic for step-therapy and indication-specific routing for GLP-1s, streamlining the process for high-volume endocrinology PAs. This ensures documentation aligns with payer criteria and accelerates approvals.

Critical Documentation for Endocrinology PAs

A1c levels and documented trials of prior medications (e.g., metformin)
Body Mass Index (BMI) and lifestyle modification documentation for obesity indications
Insulin-requiring status or hypoglycemia history for CGM coverage
Ejection fraction or eGFR thresholds for SGLT2 inhibitor indications beyond T2D
Diagnostic test results (e.g., GH stimulation testing, IGF-1 levels) for growth hormone therapy
Patient training and adherence records for insulin pumps and CGMs

Reducing Denial Rates and Administrative Burden

Common denial reasons in endocrinology, such as GLP-1 obesity-indication coverage gaps, step therapy requirements, and CGM denials for non-insulin-requiring T2D, can be mitigated through Klivira's intelligent automation. By proactively identifying and addressing documentation gaps and payer-specific criteria, Klivira helps practices reduce manual rework, improve first-pass approval rates, and free up staff for patient care.

Frequently asked questions

How does Klivira handle GLP-1 prior authorizations for both T2D and obesity indications?

Klivira's platform is designed with indication-specific routing logic, differentiating between T2D and obesity criteria for GLP-1 RAs. It prompts for relevant documentation such as A1c, prior medication trials for T2D, or BMI and weight management history for obesity, ensuring payer-specific requirements are met.

Can Klivira automate re-authorizations for continuous glucose monitors (CGMs)?

Yes, Klivira supports the automation of CGM re-authorization cycles. The platform tracks re-authorization dates and facilitates the submission of necessary adherence documentation, such as device usage logs and continued medical necessity, per payer requirements.

What EMR systems does Klivira integrate with for endocrinology workflows?

Klivira integrates with leading EMR systems using industry standards like SMART on FHIR, enabling seamless data exchange for prior authorization workflows. This allows endocrinology practices to initiate PAs directly from their existing clinical systems, minimizing duplicate data entry.

How does Klivira manage payer-specific criteria variations for insulin pumps?

Klivira's dynamic policy engine maintains an up-to-date library of payer-specific criteria for insulin pumps, including requirements for diabetes diagnosis, insulin-requiring status, and prior MDI trials. The platform guides users to provide the exact documentation needed for each payer, including those managed by platforms like Cohere Health.

Does Klivira support submissions to Cohere Health for both medical and pharmacy benefits?

Klivira connects with payer systems, including those that leverage platforms like Cohere Health, to facilitate prior authorization submissions across both medical and pharmacy benefits. This comprehensive approach ensures that all endocrinology-related PAs, from GLP-1s to insulin pumps, are routed efficiently.